Literature DB >> 19864613

A major role for the minor capsid protein of human papillomavirus type 16 in immune escape.

Laura M Fahey1, Adam B Raff, Diane M Da Silva, W Martin Kast.   

Abstract

High-risk human papillomavirus (HPV) infection of the cervical epithelium is causally linked with the generation of cervical cancer. HPV does not activate Langerhans cells (LC), the APC at the site of infection, leading to immune evasion. The HPV protein responsible for inducing this immune escape has not been determined. We demonstrate that LC exposed to the minor capsid protein L2 in HPV16L1L2 virus-like particles do not phenotypically or functionally mature. However, HPV16L1 virus-like particles significantly induce activation of LC. Our data suggest that the L2 protein plays a specific role in the induction of this immune escape of HPV16 through the manipulation of LC. This novel function is the first immune modulating action attributed to the L2 protein and adds significantly to our understanding of the mechanism of HPV immune escape.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864613      PMCID: PMC2947488          DOI: 10.4049/jimmunol.0902145

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 2.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

3.  Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation.

Authors:  Steven C Fausch; Laura M Fahey; Diane M Da Silva; W Martin Kast
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

4.  Interactions between papillomavirus L1 and L2 capsid proteins.

Authors:  Renée L Finnen; Kimberly D Erickson; Xiaojiang S Chen; Robert L Garcea
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 5.  Mechanisms used by human papillomaviruses to escape the host immune response.

Authors:  Shreya Kanodia; Laura M Fahey; W Martin Kast
Journal:  Curr Cancer Drug Targets       Date:  2007-02       Impact factor: 3.428

6.  Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells.

Authors:  Steven C Fausch; Diane M Da Silva; W Martin Kast
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

Review 7.  HPV: from infection to cancer.

Authors:  M A Stanley; M R Pett; N Coleman
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

8.  Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection.

Authors:  Rongcun Yang; William H Yutzy; Raphael P Viscidi; Richard B S Roden
Journal:  J Biol Chem       Date:  2003-01-30       Impact factor: 5.157

9.  Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses.

Authors:  Steven C Fausch; Diane M Da Silva; Michael P Rudolf; W Martin Kast
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.

Authors:  P Tan; C Anasetti; J A Hansen; J Melrose; M Brunvand; J Bradshaw; J A Ledbetter; P S Linsley
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  29 in total

Review 1.  Persistence of human papillomavirus infection: keys to malignant progression.

Authors:  Jason Bodily; Laimonis A Laimins
Journal:  Trends Microbiol       Date:  2010-11-01       Impact factor: 17.079

2.  Functional analysis of HPV-like particle-activated Langerhans cells in vitro.

Authors:  Lisa Yan; Andrew W Woodham; Diane M Da Silva; W Martin Kast
Journal:  Methods Mol Biol       Date:  2015

3.  Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro.

Authors:  Andrew W Woodham; Adam B Raff; Diane M Da Silva; W Martin Kast
Journal:  Methods Mol Biol       Date:  2015

Review 4.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

5.  Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.

Authors:  Diane M Da Silva; Carly A Movius; Adam B Raff; Heike E Brand; Joseph G Skeate; Michael K Wong; W Martin Kast
Journal:  Virology       Date:  2014-02-17       Impact factor: 3.616

6.  Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years.

Authors:  Mark H Einstein; Mira Baron; Myron J Levin; Archana Chatterjee; Bradley Fox; Sofia Scholar; Jeffrey Rosen; Nahida Chakhtoura; Marie Lebacq; Robbert van der Most; Philippe Moris; Sandra L Giannini; Anne Schuind; Sanjoy K Datta; Dominique Descamps
Journal:  Hum Vaccin       Date:  2011-12-01

7.  Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.

Authors:  Andrew W Woodham; Adam B Raff; Laura M Raff; Diane M Da Silva; Lisa Yan; Joseph G Skeate; Michael K Wong; Yvonne G Lin; W Martin Kast
Journal:  J Immunol       Date:  2014-04-09       Impact factor: 5.422

8.  Effects of HPV Pseudotype Virus in Cutting E6 Gene Selectively in SiHa Cells.

Authors:  Yan-Xiang Cheng; Gan-Tao Chen; Xiao Yang; Yan-Qing Wang; Li Hong
Journal:  Curr Med Sci       Date:  2018-04-30

Review 9.  L2, the minor capsid protein of papillomavirus.

Authors:  Joshua W Wang; Richard B S Roden
Journal:  Virology       Date:  2013-05-17       Impact factor: 3.616

10.  Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.

Authors:  Diane M Da Silva; Andrew W Woodham; Joseph G Skeate; Laurie K Rijkee; Julia R Taylor; Heike E Brand; Laila I Muderspach; Lynda D Roman; Annie A Yessaian; Huyen Q Pham; Koji Matsuo; Yvonne G Lin; Greg M McKee; Andres M Salazar; W Martin Kast
Journal:  Clin Immunol       Date:  2015-09-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.